Helix Pharma (Pvt.) Ltd.
Syed Zeeshan has extensive experience in quality assurance and microbiology within the pharmaceutical industry, currently serving as Assistant Manager Quality Assurance at Helix Pharma (Pvt.) Ltd. since October 2022, focusing on in-process control, aseptic process simulations, and annual product quality reviews. Previous roles include Assistant Manager Microbiology at Abbott and multiple positions at Sanofi, where responsibilities ranged from environmental monitoring to microbial testing. Earlier career experience includes roles at Brookes Pharmaceutical Laboratories, Bosch Pharmaceuticals, and other companies, highlighting expertise in microbiological testing, area monitoring, and quality control processes. Syed holds a Master of Science in Microbiology from Karachi University.
This person is not in any teams
This person is not in any offices
Helix Pharma (Pvt.) Ltd.
2 followers
Helix Pharma Private Limited is a Pakistan based pharmaceutical company incorporated in the year 1960, member of the Hakimsons Group established since 1921, principally engaged in the manufacture of life saving drugs. A technical collaboration in 1965 with Takeda Pharmaceutical Company of Japan was forged to build a world class pharmaceutical factory. The group’s journey in the last 100 years has been one that has gone through many political and economic cycles and has stood witness to the scientific evolution in medicine as well as very dramatic change in the regulations that primarily govern the pharmaceutical industry. Adapting to these changes has been a key factor in our success, as has been the ability to remodel our operations to best meet the needs of the medical community. Our commitment to preserving the environment and our support to local communities through health and educational initiatives affords us an opportunity to give back society in the spirit of compassion and shared human values. In order to reduce our carbon foot print we are in the process of converting 80% of the electricity needs of all our industrial and commercial facilities to renewable energy. In the next seven years we anticipate our complete fleet of vehicles will go electric. Several government registered local charities are recipients of our grant that include hospitals, school, blood banks and other special interest initiatives. Pharmaceuticals Portfolio: In addition to an extensive range of branded generics that cover 75% of all therapeutic classes and products manufactured under license, we have a range of imported biological and oncology drugs. Herbals / Nutraceuticals: Our range of nutraceutical/herbal proprietary formulations has been developed, tested and marketed with an aim to capture the growing and promising area of Alternative Medicine. Investing in the right direction is essential for a sustainable tomorrow...